dual PPAR alpha/gamma agonists (BMS)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual PPAR alpha/gamma agonists (BMS)
Drug Alias Namedual PPAR alpha/gamma agonists (BMS)dual PPAR alpha/gamma agonists (Bristol-Myers Squibb)BMS-759509
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonistsPeroxisome proliferator-activated receptor α agonists
TargetsPeroxisome proliferator-activated receptor γPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsLipid Metabolism DisordersDiabetes MellitusNutritional and Metabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsLipid Metabolism DisordersDiabetes MellitusNutritional and Metabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A